# Escalante Bioscience, Inc. — Form D

Escalante Bioscience, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-17. The offering totals $6.7M, of which $6.7M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2024-05-17
- Form: D
- Accession: 0001739074-24-000004
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $6.7M
- Amount sold: $6.7M
- Investors: 17
- Date of first sale: 2024-05-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513684

## Issuer

- Name: Escalante Bioscience, Inc.
- CIK: 0002023832
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 953 INDIANA ST., SAN FRANCISCO, CA, 94107
- Phone: (415) 275-0404

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Nicholas R Boyd | Director | San Francisco, CA |
| Ching-Yun Hsu | Director | San Francisco, CA |
| April D Schleck | Director | San Francisco, CA |
| Akshay R Tambe | Director | San Francisco, CA |
| Ching-Yun Hsu | Executive Officer | San Francisco, CA |
| April D Schleck | Executive Officer | San Francisco, CA |

## More

- [CIK 2023832 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2023832&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001739074-24-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.